Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program
Titel:
Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program
Auteur:
Shen, Qi Xu-Monette, Zijun Y. Manyam, Ganiraju C. Visco, Carlo Tzankov, Alexander Cao, Xin Deng, Lijuan Montes-Moreno, Santiago Dybkær, Karen Chiu, April Orazi, Attilio Zu, Youli Bhagat, Govind Richards, Kristy L. Hsi, Eric D. Choi, William W.L. Han van Krieken, J. Huh, Jooryung Ponzoni, Maurilio Ferreri, Andrés J.M. Farnen, John P. Møller, Michael B. Winter, Jane N. Piris, Miguel A. Medeiros, L. Jeffrey Young, Ken H.